The medicinal landscape in this country is increasingly characterized by a appearance toward market consolidation, with a handful of major companies wielding significant influence. These sector giants, often bolstered by extensive distribution networks and robust brand recognition, present a challenging picture for competition and accessible health

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces growing concerns about monopolies. A few dominant firms control a significant share of the market, potentially limiting competition and driving up prices for consumers. This situation raises worries about the long-term impact on patient access to affordabl